Bicalutamide and Ridaforolimus in Men With Prostate Cancer (MK-8669-002)
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
This study will look to see if the combination of ridaforolimus and bicalutamide works better
than placebo and bicalutamide in men with prostate cancer.